ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About N/A of AGLE shares are held by financial institutions. YU FAN is the top corporate investor, holding 737K shares valued at $16.45M. A 17.16% stake in Aeglea BioTherapeutics, Inc. is owned by the company. VR ADVISER, LLC owns 295.03K shares valued at $3.61M, which translates its holding of 0.31% of the stake in the company.
Among the AGLE insiders holding of N/A of the stake in company, LILLY ELI & CO, 10 percent owner, holds the largest shares of 2.57M. NOVARTIS BIOVENTURES LTD, , is the second largest AGLE insider with ownership of 2.18M shares. ORBIMED ADVISORS LLC, 10 percent owner, stands third with possession of 1.47M shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AGLE shares is null, representing N/A of the company's common stock.
VR ADVISER, LLC, in the last quarter, reduced its stake in AGLE by -95.35% restricting it's holding to 295.03 thousand shares of worth nearly $3.61M. YU FAN also lessened -81.62% of the AGLE shares from its portfolio, reducing its holding to 20.59 thousand shares of worth $347.80K. JPMORGAN CHASE & CO also shunned AGLE shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, YU FAN increased its stake in AGLE by 100% in the last quarter. The institutional holder raised its holding to 737 thousand shares having worth more than $16.45M. N/A also added N/A more shares of AGLE to its portfolio, raising its holding to - shares of worth -. N/A also increased its AGLE shares holding by N/A which brought its holding to - shares worth -.
The insider with the most stakes in AGLE is LILLY ELI & CO , 10 percent owner at the company. Additionally, AGLE stock is highly held by Novartis Bioventures Ltd and 10 percent owner ORBIMED ADVISORS LLC among others.
Company executives, directors, and other insiders own N/A percent of Aeglea BioTherapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which AGLE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SCHUCHART AARON and NOVARTIS BIOVENTURES LTD.
There have been 0 transaction(s) during the past 6-months in which Aeglea BioTherapeutics, Inc. insiders have bought stock, totalling 0 shares
Around 0 Aeglea BioTherapeutics, Inc. shares are held by insiders, which represents about N/A of AGLE stock.
AGLE 10 percent owner, LILLY ELI & CO holds the largest portfolio of the company's shares. AGLE shares owned by LILLY total nearly 2.57 million.
YU FAN is the largest institutional owner in AGLE which holds 737 thousand shares worth $16.45M or 17.16% of the total AGLE shares outstanding followed by VR ADVISER, LLC with ownership of 295.03 thousand shares representing 0.31% of the AGLE ownership. YU FAN is the third largest stakeholder with 20.59 thousand shares or 0.02% of the ownership worth more than $347.80K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AGLE is concerned, it is a stock which is optionable.
Number of AGLE shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, N/A shares of AGLE are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AGLE has N/A shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AGLE is N/A.